Vitamin D and the mammary gland: a review on its role in normal development and breast cancer Full Text
Breast Cancer Research,  Review Article

Lopes N. et al .– The present review highlights research data concerning the function of Vitamin D hormone in the mammary gland, with a special focus on breast carcinogenesis. Hence, and although the available data are controversial, the authors consider not only updated information on the epidemiology of vitamin D in breast cancer and its potential value as a therapeutic agent or prophylactic (with an emphasis on molecular mechanisms and effectors of vitamin D action), but include data on its role in other stages of breast cancer progression as well. Accordingly, they also review data on the influence of vitamin D in the development of normal breast and the expression of vitamin D–related proteins (VDR, CYP27B1 and CYP24A21) in benign mammary lesions and ductal carcinomas in situ.

  • Breast cancer is a heterogeneous disease associated with diverse biological behaviours and clinical outcome.
  • Although some molecular subgroups of breast cancer have a targeted therapy, the most aggressive tumours still lack a molecular target.
  • Despite vitamin D being classically associated with the physiological role of calcium regulation and phosphate transport in bone metabolism, several studies have demonstrated a wide range of functions for this hormone, which are particularly important in the field of cancer.
  • The mechanisms underlying the protective actions of vitamin D in cancer development are only sparsely understood, but evidence shows that vitamin D participates in cell growth regulation, apoptosis and cell differentiation.
  • In addition, it has been implicated in the suppression of cancer cell invasion, angiogenesis and metastasis.
  • Most of vitamin D biological actions are mediated by the vitamin D receptor and the synthesis and catabolism of this hormone are regulated by the enzymes CYP27B1 and CYP24A1.
  • The data described provide evidence for an essential role of vitamin D in normal development of the mammary gland and breast cancer.
  • Epidemiological studies are conflicting and their results not consistent, with the current view indicating no protective role for vitamin D in breast cancer development.
  • Still, the different functions and effects of vitamin D on cancer cell biology, such as the cell cycle, apoptosis, invasion and metastasis, as well as angiogenesis, virtually bring together the entire spectrum of tumour development under its purview.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Obstetrics & Gynecology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Obstetrics & Gynecology Articles

1 Genome-wide mapping of copy number variations in patients with both anorectal malformations and central nervous system abnormalities Birth Defects Research Part A: Clinical and Molecular Teratology, October 17, 2014    Clinical Article

2 Genome-based risk prediction for early stage breast cancer Full Text The Oncologist, September 24, 2014    Free full text    Review Article

3 Microbes central to human reproduction American Journal of Reproductive Immunology, September 30, 2014    Clinical Article

4 Hypophysiotropic gonadotropin-releasing hormone projections are exposed to dense plexuses of kisspeptin, neurokinin B and substance P immunoreactive fibers in the human: a study on tissues from postmenopausal women Neuroendocrinology, October 9, 2014    Clinical Article

5 Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells The American Journal of Chinese Medicine (AJCM), October 20, 2014    Clinical Article

6 Fetal facial profile markers in second and third trimester trisomy 18 fetuses Ultrasound in Obstetrics & Gynecology, September 16, 2014    Clinical Article

7 Screening for trisomies 21, 18 and 13 cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks Ultrasound in Obstetrics & Gynecology, October 2, 2014    Clinical Article

8 Mutational analysis of TOX3 in Chinese Han women with polycystic ovary syndrome Reproductive BioMedicine Online, October 7, 2014    Clinical Article

9 Gene variation and premature ovarian failure: A meta-analysis European Journal of Obstetrics & Gynecology and Reproductive Biology, October 28, 2014    Clinical Article

10 Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients The Breast, October 2, 2014    Clinical Article

11 Blastocentesis: A source of DNA for preimplantation genetic testing. Results from a pilot study Fertility and Sterility, October 30, 2014

12 Cell-free fetal DNA screening in the United States: A cost analysis of screening strategies Ultrasound in Obstetrics & Gynecology, October 28, 2014    Clinical Article

13 Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing Obstetrics and Gynecology, October 29, 2014

14 The consistency of experts' evaluation of obstetric claims for compensation BJOG: An International Journal of Obstetrics and Gynaecology, September 8, 2014    Clinical Article

15 Array comparative genomic hybridization and fetal congenital heart defects - A systematic review and meta-analysis Ultrasound in Obstetrics & Gynecology, October 28, 2014    Evidence Based Medicine    Review Article

16 Relationship between bent long bones, bent scapulae, and wavy ribs: Malformations or variations? Birth Defects Research Part B: Developmental and Reproductive Toxicology, October 3, 2014    Review Article

17 Molecular characterization of exosomes and their microRNA cargo in human follicular fluid: bioinformatic analysis reveals that exosomal microRNAs control pathways involved in follicular maturation Fertility and Sterility, September 29, 2014

18 A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome Prenatal Diagnosis, October 21, 2014

19 Polymorphisms in genes coding for the NK-cell receptor NKG2D and its ligand MICA in recurrent miscarriage American Journal of Reproductive Immunology, September 24, 2014    Clinical Article

20 Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients Medical Oncology, October 6, 2014    Clinical Article
Exclusive Author Commentary

Indexed Journals in Obstetrics & Gynecology: Obstetrics and Gynecology, American Journal of Obstetrics and Gynecologymore